TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

被引:186
作者
Sun, C. [1 ]
Dobi, A. [1 ,6 ]
Mohamed, A. [1 ]
Li, H. [1 ]
Thangapazham, R. L. [1 ]
Furusato, B. [1 ,2 ]
Shaheduzzaman, S. [1 ]
Tan, S-H [1 ]
Vaidyanathan, G. [1 ]
Whitman, E. [1 ,3 ]
Hawksworth, D. J. [1 ,3 ]
Chen, Y. [1 ]
Nau, M. [4 ]
Patel, V. [5 ]
Vahey, M. [4 ]
Gutkind, J. S. [5 ]
Sreenath, T. [1 ]
Petrovics, G. [1 ]
Sesterhenn, I. A. [2 ,6 ]
McLeod, D. G. [1 ,3 ,6 ]
Srivastava, S. [1 ,6 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Dept Surg, Rockville, MD 20852 USA
[2] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA
[3] Walter Reed Army Med Ctr, Urol Serv, Dept Surg, Washington, DC 20307 USA
[4] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA
[5] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, Natl Inst Hlth, Bethesda, MD USA
[6] US Mil Canc Inst, Washington, DC USA
关键词
ERG; prostate cancer; oncogene; C-MYC; PSA; TMPRSS2-ERG;
D O I
10.1038/onc.2008.183
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high prevalence of TMPRSS2-ERG rearrangements (similar to 60%) in prostate cancer (CaP) leads to androgenic induction of the ETS-related gene (ERG) expression. However, the biological functions of ERG overexpression in CaP remain to be understood. ERG knockdown in TMPRSS2-ERG expressing CaP cells induced striking morphological changes and inhibited cell growth both in cell culture and SCID mice. Evaluation of the transcriptome and specific gene promoters in ERG siRNA-treated cells and investigation of gene expression signatures of human prostate tumors revealed ERG-mediated activation of C-MYC oncogene and the repression of prostate epithelial differentiation genes (PSA and SLC45A3/Prostein). Taken together, these data combining cell culture and animal models and human prostate tumors reveal that ERG overexpression in prostate tumor cells may contribute to the neoplastic process by activating C-MYC and by abrogating prostate epithelial differentiation as indicated by prostate epithelial specific markers.
引用
收藏
页码:5348 / 5353
页数:6
相关论文
共 22 条
[1]   High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults [J].
Baldus, Claudia D. ;
Burmeister, Thomas ;
Martus, Peter ;
Schwartz, Stefan ;
Goekbuget, Nicola ;
Bloomfield, Clara D. ;
Hoelzer, Dieter ;
Thiel, Eckhard ;
Hofmann, Wolf K. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4714-4720
[2]   Role of the TMPRSS2-ERG gene fusion in prostate cancer [J].
Chinnaiyan, Arul M. .
NEOPLASIA, 2008, 10 (02) :177-U23
[3]   Inflammation in prostate carcinogenesis [J].
De Marzo, Angelo M. ;
Platz, Elizabeth A. ;
Sutcliffe, Siobhan ;
Xu, Jianfeng ;
Gronberg, Henrik ;
Drake, Charles G. ;
Nakai, Yasutomo ;
Isaacs, William B. ;
Nelson, William G. .
NATURE REVIEWS CANCER, 2007, 7 (04) :256-269
[4]   TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications [J].
Demichelis, Francesca ;
Rubin, Mark A. .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (11) :1185-1186
[5]   Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer [J].
Furusato, Bungo ;
Gao, Chun-Ling ;
Ravindranath, Lakshmi ;
Chen, Yongmei ;
Cullen, Jennifer ;
McLeod, David G. ;
Dobi, Albert ;
Srivastava, Shiv ;
Petrovics, Gyorgy ;
Sesterhenn, Isabell A. .
MODERN PATHOLOGY, 2008, 21 (02) :67-75
[6]   TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming [J].
Iljin, Kristiina ;
Wolf, Maija ;
Edgren, Henrik ;
Gupta, Santosh ;
Kilpinen, Sami ;
Skotheim, Rolf I. ;
Peltola, Mari ;
Smit, Frank ;
Verhaegh, Gerald ;
Schalken, Jack ;
Nees, Matthias ;
Kallioniemi, Olli .
CANCER RESEARCH, 2006, 66 (21) :10242-10246
[7]   A causal role for ERG in neoplastic transformation of prostate epithelium [J].
Klezovitch, Olga ;
Risk, Michael ;
Coleman, Ilsa ;
Lucas, Jared M. ;
Null, Manda ;
True, Lawrence D. ;
Nelson, Peter S. ;
Vasioukhin, Valeri .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (06) :2105-2110
[8]  
Korenchuk S, 2001, IN VIVO, V15, P163
[9]  
Lin BY, 1999, CANCER RES, V59, P4180
[10]   Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics [J].
Marcucci, G ;
Mrózek, K ;
Bloomfield, CD .
CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) :68-75